Repros Therapeutics (RPRX) Reinstitutes At-The-Market Offering
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Join SI Premium – FREE
In an 8-K filing this afternoon, recent momentum over Repros Therapeutics Inc. (Nasdaq: RPRX) disclsoed that the company has decided to reinstitute its at-the-market offering of its common stock, pursuant to the Equity Distribution Agreement dated February 12, 2010 between the Company and Ladenburg Thalmann & Co. Inc.
Shares of Repros Therapeutic have surged over 130% since December 23 following positive drug data.
Cumulative through December 30, 2010, the Company has sold 2,448,572 shares of its common stock in its at-the-market offering, at a weighted average share price of $2.77, for proceeds of approximately $6.4 million, net of expenses.
Pursuant to General Instruction I.B.6. of Form S-3, the Company may not sell more than one-third of the aggregate market value of its common stock held by non-affiliates during a period of 12 calendar months immediately prior to, and including, the date of such sale of such common stock. The Company may from time to time elect to cease or restart its at-the-market offering without the filing of a Form 8-K
Shares of Repros Therapeutic have surged over 130% since December 23 following positive drug data.
Cumulative through December 30, 2010, the Company has sold 2,448,572 shares of its common stock in its at-the-market offering, at a weighted average share price of $2.77, for proceeds of approximately $6.4 million, net of expenses.
Pursuant to General Instruction I.B.6. of Form S-3, the Company may not sell more than one-third of the aggregate market value of its common stock held by non-affiliates during a period of 12 calendar months immediately prior to, and including, the date of such sale of such common stock. The Company may from time to time elect to cease or restart its at-the-market offering without the filing of a Form 8-K
Are you missing key trading opportunities? Upgrade to StreetInsider Premium and get a step ahead of the market - FREE TRIAL!
Create E-mail Alert Related Categories
Equity Offerings, Momentum MoversRelated Entities
Ladenburg Thalmann Financial Services, S3Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
